This portion of our website contains archival information. Archived information should be considered accurate only as of the date listed next to the event. Archived information may be superseded by more recent information we have disclosed in later presentations, press releases, filings with the Securities and Exchange Commission or otherwise. Archived information may contain forward-looking statements. Actual results may materially differ based on several factors, including those described in the archived information, press releases and our filings with the SEC.
2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999
- May 11, 2009
Targacept Reports First Quarter 2009 Financial Results - May 11, 2009
Targacept Announces Positive Top-Line Results from Phase II Study of AZD3480 in Adult ADHD - May 04, 2009
Targacept to Report First Quarter Financial Results on May 11, 2009 - April 23, 2009
Targacept Initiates Phase 2 Study of TC-5214 in Patients with Resistant Hypertension - March 11, 2009
Targacept Provides Update on TC-6499 and Pain Program in GlaxoSmithKline Alliance - February 12, 2009
Targacept Reports Fourth Quarter and 2008 Financial Results - February 05, 2009
Targacept to Report Fourth Quarter and 2008 Financial Results on February 12, 2009 - February 03, 2009
Targacept to Present at BIO CEO & Investor Conference